International Journal of Hematology

, Volume 81, Issue 3, pp 269–270 | Cite as

Trisomy 22 as the Sole Karyotypic Abnormality in Myelodysplastic Syndrome

  • Tohru Takahashi
  • Sayaka Harada
  • Mariko Oki
  • Mitsuru Yoshimoto
  • Masayuki Tsujisaki
Letter to the Editor


Acute Myeloid Leukemia Chronic Myeloid Leukaemia Myelodysplastic Syndrome Chronic Myeloid Leukaemia Patient Peripheral Blood Stem Cell Transplan 


  1. 1.
    Mensink E, van de Locht A, Schattenberg A, et al. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. Br J Haematol. 1998;102:768–774.CrossRefPubMedGoogle Scholar
  2. 2.
    Eder M, Battmer K, Kafert S, Stucki A, Ganser A, Hertenstein B. Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation. Leukemia. 1999;13:1383–1389.CrossRefGoogle Scholar
  3. 3.
    Niemeyer MMG, Haak HL, Augustinus E, den Nijs-van Weert JI, Leeksma CHW. Trisomy of chromosome 22 in acute myelomonocytic leukemia. Cancer Genet Cytogenet. 1986;20:371–374.CrossRefGoogle Scholar
  4. 4.
    Najfeld V, Seremetis S, Troy K, Uehlinger J, Schwartz P, Cuttner J. Trisomy 22—a new abnormality found in acute leukemia characterized by eosinophilia and monocytoid blasts expressing immature differentiation antigens. Cancer Genet Cytogenet. 1986;23:105–114.CrossRefGoogle Scholar
  5. 5.
    Grois N, Nowotny H, Tyl E, Krieger O, Kier P, Haas OA. Is trisomy 22 in acute myeloid leukemia a primary abnormality or only a secondary change associated with inversion 16? Cancer Genet Cytogenet. 1989;43:119–129.CrossRefPubMedGoogle Scholar
  6. 6.
    Pinheiro RF, Chauffaille MLLF, Vicari P, et al. Trisomy 22: a subclone marker? Cancer Genet Cytogenet. 2003;143:85–86.CrossRefGoogle Scholar
  7. 7.
    Wong KF, Kwong YL. Trisomy 22 in acute myeloid leukemia: a marker for myeloid leukemia with monocytic features and cytogenetically cryptic inversion 16. Cancer Genet Cytogenet. 1999;109:131–133.CrossRefPubMedGoogle Scholar
  8. 8.
    Langabeer SE, Grimwade D, Walker H, et al. A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/ MYH11 respectively in acute myeloid leukaemia. Br J Haematol. 1998; 101:338–334.CrossRefPubMedGoogle Scholar
  9. 9.
    Gradl G, Tesch H, Schwieder G, Wagner T, Fonatsch C. Translocation of c-abl oncogene and PDGFB (c-sis) gene in a case of CML with 46,XY, t(22;22). Blut. 1989;58:279–285.CrossRefPubMedGoogle Scholar
  10. 10.
    Ida K, Kitabayashi I, Taki T, et al. Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22) (q23;q13). Blood. 1997;15;90:4699–4704.Google Scholar
  11. 11.
    Kitabayashi I, Aikawa Y, Yokoyama A, et al. Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation. Leukemia. 2001;15:89–94.CrossRefGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2005

Authors and Affiliations

  • Tohru Takahashi
    • 1
  • Sayaka Harada
    • 1
  • Mariko Oki
    • 1
  • Mitsuru Yoshimoto
    • 1
  • Masayuki Tsujisaki
    • 1
  1. 1.Department of Hematology and GastroenterologyCaress Alliance Tenshi HospitalSapporoJapan

Personalised recommendations